Get started
Author

Madeleine A. King

Observed name: Madeleine King
ORCID: 0009-0003-1765-2523
Observed ORCID: 0009-0003-1765-2523
OpenAlex ID: A5067767770
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature
2021 · Joshua W. Branstetter, Amy L. Kiskaddon, et al. · Seminars in Thrombosis and Hemostasis · 24
Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective
2022 · Jacqueline C. Dela-Pena, Madeleine A. King, et al. · Journal of Oncology Pharmacy Practice · 6
Evaluation of Continuous Infusion Vancomycin in a Pediatric Hematology/Oncology Population
2024 · Madeleine A. King, Shane J. Cross, et al. · The Pediatric Infectious Disease Journal · 3
It’s “Blin” a Long Time Coming: The Rise of Blinatumomab in Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
2025 · Lauren T. Shinn, Madeleine A. King, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
Posaconazole dosing of enteral formulations in infants and young children to achieve therapeutic concentrations
2025 · Jeffrey Harrington, Gianni Scappaticci, et al. · Journal of Antimicrobial Chemotherapy · 1
Diaries or questionnaires for collecting self-reported healthcare utilisation and patient cost data? CHERE Project Report No 20
2003 · Patricia Kenny, Ajsa Mahmic, et al. · RePEc: Research Papers in Economics · 1
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study
2026 · Benjamin J. Lerman, Madeleine King, et al. · Pediatric Blood & Cancer
Dementia Care Mapping and Patient-Centred Care in Australian residential homes: An economic evaluation of the CARE Study, CHERE Working Paper 2008/4
2008 · Richard Norman, Marion Haas, et al. · RePEc: Research Papers in Economics
Works count: 8
Citation count: 37
H-index: 3
I10-index: 1
Year
Topic
Type